ImmunoPrecise Antibodies Ltd.
IPA
$0.4379
$0.01092.55%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.23M | -20.07M | -19.98M | -19.62M | -10.11M |
| Total Depreciation and Amortization | 4.14M | 4.14M | 4.11M | 4.22M | 3.45M |
| Total Amortization of Deferred Charges | 64.10K | 51.40K | 38.20K | 25.80K | 1.10M |
| Total Other Non-Cash Items | 22.83M | 9.61M | 9.69M | 10.47M | 2.27M |
| Change in Net Operating Assets | 431.80K | 588.90K | 2.08M | 1.76M | 446.10K |
| Cash from Operations | -5.77M | -5.69M | -4.06M | -3.14M | -2.84M |
| Capital Expenditure | -1.15M | -948.00K | -1.12M | -1.03M | -541.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | -109.40K | -96.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.80K | -68.20K | -77.80K | -14.10K | -25.90K |
| Cash from Investing | -1.14M | -1.02M | -1.20M | -1.15M | -663.10K |
| Total Debt Issued | 4.24M | 4.06M | 2.60M | -- | -- |
| Total Debt Repaid | -1.44M | -1.43M | -1.33M | -1.34M | -1.42M |
| Issuance of Common Stock | 13.64M | 3.87M | 2.85M | 2.36M | 936.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.73M | 4.77M | 3.02M | 749.70K | -359.20K |
| Foreign Exchange rate Adjustments | -190.60K | 106.90K | 158.60K | -27.20K | 67.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.64M | -1.83M | -2.08M | -3.57M | -3.80M |